Dataset Information


The prognostic role of plasma fibrinogen in adult secondary hemophagocytic lymphohistiocytosis.



In adult patients with secondary hemophagocytic lymphohistiocytosis (sHLH), no valid immune biomarker has been available for predicting the prognosis of untreated sHLH patients.


Circulating plasma levels of fibrinogen (FIB) were measured at diagnosis in 293 cases of adult sHLH. We categorized FIB levels into tertiles. Multivariable Cox proportional hazards models were used to evaluate the relationship between FIB and survival. Restricted cubic spline models and two-piecewise Cox proportional hazards models were used to address the nonlinear association between FIB and mortality.


During a median follow-up of 52 (interquartile ranges, 18-221) days, 208 deaths occurred, with 137 deaths in malignancy-associated hemophagocytic lymphohistiocytosis (MHLH) and 71 deaths in non-malignancy-associated hemophagocytic lymphohistiocytosis (non-MHLH). After multivariable adjustment, compared with the highest tertile of FIB, the hazard ratios (HRs) with 95% confidence intervals (CIs) of survival for tertile 2 and tertile 1 were 1.06 (0.90-1.24) and 0.84 (0.71-0.98), respectively. The restricted cubic spline curve displayed a nonlinear and inverse relationship between FIB and mortality. Furthermore, the threshold effect analysis demonstrated that the inflection point for the curve was at an FIB level of 1.76 g/L. The HRs (95% CIs) for survival were 0.68 (0.55-0.83) and 1.08 (0.96-1.21) on the left and right side of the inflection point, respectively.


These results suggest that plasma fibrinogen is nonlinearly and inversely associated with the risk of mortality in adult secondary hemophagocytic lymphohistiocytosis.


PROVIDER: S-EPMC7690012 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7231517 | BioStudies
1000-01-01 | S-EPMC3943310 | BioStudies
2019-01-01 | S-EPMC6369774 | BioStudies
2017-01-01 | S-EPMC5664400 | BioStudies
2020-01-01 | S-EPMC7589537 | BioStudies
2021-01-01 | S-EPMC7227559 | BioStudies
2020-01-01 | S-EPMC7244444 | BioStudies
2017-01-01 | S-EPMC5549388 | BioStudies
2019-01-01 | S-EPMC6518152 | BioStudies
2020-01-01 | S-EPMC7252029 | BioStudies